Introduction of magnetic and supermagnetic nanoparticles in new approach of targeting drug delivery and cancer therapy application. (2nd January 2020)
- Record Type:
- Journal Article
- Title:
- Introduction of magnetic and supermagnetic nanoparticles in new approach of targeting drug delivery and cancer therapy application. (2nd January 2020)
- Main Title:
- Introduction of magnetic and supermagnetic nanoparticles in new approach of targeting drug delivery and cancer therapy application
- Authors:
- Avval, Zhila Mohajeri
Malekpour, Leila
Raeisi, Farzad
Babapoor, Aziz
Mousavi, Seyyed Mojtaba
Hashemi, Seyyed Alireza
Salari, Marjan - Abstract:
- Abstract: In this article, the recent applications of different types of magnetic nanoparticles such as α-Fe2 O3 (hematite), γ-Fe2 O3 (maghemite), Fe3 O4 (magnetite), hexagonal (MFe12 O19 ), garnet (M3 Fe5 O12 ) and spinel (MFe2 O4 ), where M represents one or more bivalent transition metals (Mn, Fe, Co, Ni, Ba, Sr, Cu, and Zn), and different materials for coating the surface of magnetic nanoparticles like poly lactic acid (PLA), doxorubicin hydrophobic (DOX-HCL), paclitaxel (PTX), EPPT-FITC, oleic acid, tannin, 3-Aminopropyltriethoxysilane (APTES), multi-wall carbon nanotubes (CNTs), polyethylenimine (PEI) and polyarabic acid in drug delivery, biomedicine and treatment of cancer, specially chemotherapy, are reviewed. MNPs possess large surface area to volume ratios because of their nano-size, low surface charge at physiological pH and they aggregate easily in solution due to their essential magnetic nature. These materials are widely used in biology and medicine in many cases. One targeted delivery technique that has gained prominence in recent years is the use of magnetic nanoparticles. In these systems, therapeutic compounds are attached to biocompatible magnetic nanoparticles and magnetic fields generated outside the body are focused on specific targets in vivo. The fields capture the particle complex, resulting in enhanced delivery to the target site. Also, the application of brand new supermagnetic nanoparticles, like Ba, SrFe12 O19, is considered and studied in thisAbstract: In this article, the recent applications of different types of magnetic nanoparticles such as α-Fe2 O3 (hematite), γ-Fe2 O3 (maghemite), Fe3 O4 (magnetite), hexagonal (MFe12 O19 ), garnet (M3 Fe5 O12 ) and spinel (MFe2 O4 ), where M represents one or more bivalent transition metals (Mn, Fe, Co, Ni, Ba, Sr, Cu, and Zn), and different materials for coating the surface of magnetic nanoparticles like poly lactic acid (PLA), doxorubicin hydrophobic (DOX-HCL), paclitaxel (PTX), EPPT-FITC, oleic acid, tannin, 3-Aminopropyltriethoxysilane (APTES), multi-wall carbon nanotubes (CNTs), polyethylenimine (PEI) and polyarabic acid in drug delivery, biomedicine and treatment of cancer, specially chemotherapy, are reviewed. MNPs possess large surface area to volume ratios because of their nano-size, low surface charge at physiological pH and they aggregate easily in solution due to their essential magnetic nature. These materials are widely used in biology and medicine in many cases. One targeted delivery technique that has gained prominence in recent years is the use of magnetic nanoparticles. In these systems, therapeutic compounds are attached to biocompatible magnetic nanoparticles and magnetic fields generated outside the body are focused on specific targets in vivo. The fields capture the particle complex, resulting in enhanced delivery to the target site. Also, the application of brand new supermagnetic nanoparticles, like Ba, SrFe12 O19, is considered and studied in this paper. … (more)
- Is Part Of:
- Drug metabolism reviews. Volume 52:Number 1(2020)
- Journal:
- Drug metabolism reviews
- Issue:
- Volume 52:Number 1(2020)
- Issue Display:
- Volume 52, Issue 1 (2020)
- Year:
- 2020
- Volume:
- 52
- Issue:
- 1
- Issue Sort Value:
- 2020-0052-0001-0000
- Page Start:
- 157
- Page End:
- 184
- Publication Date:
- 2020-01-02
- Subjects:
- Magnetic nanoparticles -- Supermagnetic -- drug delivery -- cancer therapy -- iron oxide
Drugs -- Metabolism -- Periodicals
Pharmacokinetics -- Periodicals
Pharmaceutical Preparations -- metabolism -- Periodicals
615 - Journal URLs:
- http://informahealthcare.com/loi/dmr ↗
http://informahealthcare.com ↗ - DOI:
- 10.1080/03602532.2019.1697282 ↗
- Languages:
- English
- ISSNs:
- 0360-2532
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3629.330000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 13662.xml